RUTHERFORD, Calif.--(BUSINESS WIRE)-- The International Mental Health Research Organization (IMHRO) has announced its 2012 IMHRO Rising Star Translational Research Awards, which are sponsored by IMHRO and Johnson & Johnson Services, Inc. IMHRO and the Corporate Office of Science and Technology of Johnson & Johnson Services, Inc. identify and fund critical and cutting edge research on the causes of and cures for brain disorders. IMHRO serves as an umbrella organization to provide support for mental health research.
The 2012 IMHRO Rising Star Translational Research Award winners are Colleen McClung, Ph.D., University of Pittsburgh School of Medicine Department of Psychiatry, who is being recognized for her study “Specific HDAC inhibition as a novel treatment for bipolar disorder,” and Scott Russo, Ph.D., Mount Sinai School of Medicine Department of Neuroscience, for his study “Inflammation and Depression: translating basic discoveries into new therapeutics.”
Given the challenges of finding therapies for nervous system disorders, this award aims to encourage the community of neuroscience researchers to direct their efforts toward translational science while supporting the research of emerging leaders in the field.
The 2012 IMHRO Rising Star Translational Research Award winners were selected by IMHRO and Johnson & Johnson Services, Inc. Corporate Office of Science and Technology with the assistance and recommendations of the IMHRO scientific advisory board, which includes nine of the leading brain scientists in the world, noted for their pioneering research in their respective fields. Each Rising Star recipient will receive $250,000 to fund research for their studies.
"The results of this study,” says Dr. McClung, “will identify specific HDAC proteins to target for the development of novel therapeutics for the treatment of bipolar disorder. This will be a large step forward for the health of those who suffer from this devastating disease."
Dr. Russo adds, "These translational studies will ultimately help us to determine the antidepressant efficacy of anti-inflammatory medications that target IL6 and other inflammatory processes."
The grant recipients will be presented at the Staglin Family Vineyard Music Festival for Mental Health on September 15, 2012 at the Staglin Family Vineyard, in Rutherford, CA. Events of the day include a scientific seminar, followed by an exclusive wine reception featuring many specialized wineries from Napa, Sonoma and other wine regions of the world paired with hors d'œuvres prepared by Nancy Oakes of Boulevard in San Francisco, a concert by a legendary musical act, and a Napa Valley feast under the stars at the VIP post-concert dinner by Nancy Silverton of Pizzeria Mozza and Osteria Mozza in Los Angeles. Tickets for the lecture, exclusive wine reception and concert are $750. Tickets for the lecture, reception, concert and VIP dinner are $5000 with table of ten sponsorships beginning at $50,000. All revenues will go to mental health research projects funded by IMHRO throughout the nation. Admission to the seminar only is free.
Donations to the Music Festival for Mental Health may be made on-line at www.music-festival.org, or by sending a check to IMHRO, a 501 (c) (3) non-profit organization that sponsors the Music Festival. Please mail donations to: P.O. Box 680, Rutherford, Calif., 94573.
International Mental Health Research Organization (IMHRO) is committed to raising awareness and funding research to find preventions and cures for schizophrenia, major depression and bipolar disorder within a generation.
Psychiatric diseases cause much suffering, both for people afflicted and those who love them. Probably, this includes someone you know: 1 in 5 people lives with a psychiatric disease. It is the number 1 cause of adult disability in the world.
IMHRO is families and individuals whose lives have been touched by brain disorders—and who have seen how far mental health research has come in the last decade. Contributors to IMHRO have raised $135 million for research, changed thousands of lives, and funded stunning discoveries for better therapies now and tomorrow.
KEYWORDS: United States North America California
INDUSTRY KEYWORDS: Health Biotechnology Hospitals Mental Health